| INTRODUC TI ON
Late gadolinium enhancement (LGE) and its application in cardiac magnetic resonance (CMR) regarding the ability to discern between various cardiomyopathies, magnetic resonance angiography, firstpass perfusion, viability, and prognostic information in various pathologies make it a valuable tool in advanced noninvasive imaging. It permits detection of abnormal myocardium based on the delivery and distribution of gadolinium (Gd) in the expanded extracellular space caused by fibrosis, protein infiltration, and/or myocardial disarray.
Due to its high spatial resolution, LGE-CMR is able to distinguish scar patterns in different types of disease pathologies allowing the physician to expand on the differential diagnosis. 1 It also adds value in identifying patients who are at increased risk for sudden cardiac death (SCD). 2 Late gadolinium enhancement technique has been developed and validated for more than a decade. 3 
| SAFE T Y OF G ADOLINI UM -BA S ED CONTR A S T AG ENTS
Gadolinium (an element with paramagnetic features) is able to be temporarily magnetized when placed in an external magnetic field. It shortens the T1 relaxation and provides enhancement of contrast in the images. Gadolinium is bound to a large molecule carrier. For this reason, when injected intravenously, Gd does not enter the intercellular spaces, and is quickly washed out of the blood pool. However, in areas with abnormal myocardium due to cell damage or increased interstitial space, there is an increased uptake and washout is delayed. The distribution pattern of Gd enables us to distinguish between bright abnormal myocardium and black normal myocardium.
| RIS K WITH G ADOLINI UM -BA S ED CONTR A S T AG ENTS
Gadolinium is excreted by the kidneys and has a half-life of two hours. Similar to the other radiocontrast agents, Gd can cause contrast-induced nephropathy. Nephrogenic systemic sclerosis (NSF), a condition that resembles scleroderma, is a rare side effect of Gd contrast. The overall risk of NSF is low and has declined since Gd was implicated as the cause. Certain factors such as chronic kidney disease, multiple exposures, and/or exposure to certain Gd (nonionic, linear) agents increased the risk of developing NSF after administration. Nephrogenic systemic sclerosis has not been reported in patients with normal renal function. 
| Myocardial viability
After numerous studies with validation, LGE-CMR imaging has become the gold standard imaging modality for assessing irreversibly injured myocardium and its prognosis. 5 Additionally, the CE-MARC trial has established the superior diagnostic accuracy of LGE-CMR over single photon emission computed tomography (SPECT) in diagnosing CAD. 6 Ischemic cardiomyopathy on LGE has a distribution pattern which typically involves subendocardium. The LGE-CMR has a much higher spatial resolution than SPECT imaging which allows for more accurate detection of subendocardial infarcts even without clinical myocardial necrosis. 7 For this reason, CMR has a higher sensitivity in measurement of infarct size compared with SPECT in patients with acute myocardial infarction. 8 Additionally, a significant percent of infarcts related to a right coronary or circumflex coronary artery distribution may be missed in SPECT imaging. 9 Studies have revealed that LGE-CMR shows an inverse relationship with the extent of transmural enhancement and improvement in contractile function of the left ventricle (LV) which is valuable prognostically.
10,11
Several studies have revealed that LGE less than 25% of LV wall thickness predicts good functional recovery whereas LGE greater than 25% is associated with variable recovery of LV function following an intervention (PCI/CABG). 7 The LGE-CMR is also a useful tool to detect microvascular obstruction (MVO). This can be seen after revascularization of epicardial coronary artery which has been occluded for a prolonged period. Microvascular obstruction is seen as subendocardial areas of low signal intensity which are surrounded by enhancement indicating fibrosis.
The detection of MVO has prognostic implications as well, as it has demonstrated correlations with adverse events such as heart failure (HF), arrhythmia, and death, and it is more accurate than catheterization. 
| Stress perfusion
An MR-IMPACT trial has shown perfusion CMR to be equivalent of SPECT for CAD, eliminating the need of radiation exposure. 13 Stress perfusion CMR (using vasodilator stressor, regadenoson) is compared with resting perfusion CMR to identify areas of reduced myocardial perfusion. The perfusion defect extends from subendocardium toward the epicardium, and the severity is correlated with the extension of defect.
Poststress LGE sequences are able to distinguish between viable and nonviable myocardium in the same setting. An abnormal myocardium will show hyper enhancement due to increase in Gd concentration, whereas viable myocardium will have no contrast uptake ( Figure 1 ). 13 
| Myocardial wall motion
One of the significant advancements in stress CMR imaging is the acquisition of cine images which has allowed to assess LV volumes, function, and wall motion. To assess the wall motion on CMR, an identical pharmacological protocol similar to dobutamine stress echocardiography is used. Studies have shown that dobutamine stress CMR is safe with a higher diagnostic accuracy than dobutamine stress echocardiography. 14,15 Additionally, Jahnke et al has shown stress CMR predicts cardiovascular events in patients with known or suspected CAD. 16 Supplementation of stress CMR with
LGE-CMR allows us to assess the myocardial viability as well as perfusion of myocardium comprehensively.
| Nonischemic cardiomyopathies

| Hypertrophic cardiomyopathy (HCM)
Hypertrophic cardiomyopathy represents the most common cause of SCD in the young, including trained athletes, and an important substrate for HF disability at any age. Various genetic mutations lead to a combination of myocyte hypertrophy, disarray, and fibrosis. 17 Late gadolinium enhancement, identified in up to 80% of HCM patients, represents areas of focal interstitial expansion due to myocardial fibrosis. 17 In patients endocardial and extends toward mid-myocardium. 18 The importance of studying LGE in HCM is due to the fact that the disease has been associated with risk of malignant arrhythmias and sudden death. 2 The amount of LGE (not just the presence) in a population of asymptomatic patients with HCM was an independent predictor of all-cause and cardiovascular mortality. 18 Late gadolinium enhancement can help in iden- LGE. 19 Chan et al concluded a greater than 15% LGE increases the risk of SCD by twofold compared to patients with no LGE (Figure 2 ). 
| Idiopathic dilated cardiomyopathy (DCM)
In a significant proportion of patients with new-onset HF and normal coronary arteries on cardiac catheterization, LGE-CMR may show an evidence of prior infarction by subendocardial or transmural enhancement in coronary artery distribution. This may be secondary to vasospasm, embolic phenomenon, or spontaneous recanalization. 20 A quarter of patients with DCM (but no CAD) may have some patchy or longitudinal mid-myocardial hyper enhancement in noncoronary artery distribution which represents fibrosis and may be a foci of arrhythmias. 20 The recent study by Venero et al has provided a cardinal proof on CMR's role in predicting left ventricular assist device (LVAD) or heart transplantation requirement in patients with DCM. 21 Venero et al concluded that in patients with DCM, the presence of mid-myocardial stripe on LGE-CMR can help clinicians identify high risk patients who would need LVAD or heart transplant within 1 year of presentation. 
| Sarcoidosis
Sarcoidosis is a multisystem granulomatous disease that can affect the myocardium in 20%-30% of patients. 22 Cardiac sarcoidosis presents with conduction abnormalities, congestive HF, and potentially fatal arrhythmias. Sudden death accounts for over half of the fatalities from cardiac sarcoidosis. 23 Histological diagnosis of cardiac sarcoidosis by endomyocardial biopsy (EMB) is limited because of patchy cardiac infiltration which may result in false-negative result. 24 Recent advances in imaging with CMR and positron emission tomography (PET) have increased diagnostic yield, and hence treatment opportunities in these patients. The CMR with contrast enhancement has high specificity for sarcoidosis. 25 In a study of 155 patients with extra-cardiac sarcoidosis who underwent CMR, absence of LGE was associated with no adverse events even in patients with LV enlargement and dysfunction. 25 The
LGE-CMR images show patchy, multifocal mid-myocardial, or subepicardial enhancement, with a predilection for basal septum and lateral walls, in a noncoronary distribution. 26 Enhancement of the RV side of basal septum is a characteristic finding. Occasionally, the enhancement scan can be transmural or in any distribution. 26 Late gadolinium enhancement guided EMB may increase the diagnostic sensitivity for detecting cardiac involvement. 24 In a recent metaanalysis, presence of LGE in patients with cardiac sarcoidosis was found to be associated with increased arrhythmias and all-cause mortality ( Figure 3 ). 
| Amyloidosis
Cardiac amyloidosis is characterized by generalized deposition of amyloid fibrils in the interstitium which causes concentric thickening leading to restrictive cardiomyopathy. The typical finding of cardiac amyloidosis on LGE-CMR is the difficulty to optimally null the myocardium by choosing a T1 value. The LGE-CMR has a sensitivity and specificity of 86% for the identification of cardiac involvement in patients with systemic amyloidosis, detecting early abnormalities in patients with normal LV wall thickness, and appeared strongly related to HF severity. 28 The pattern of LGE can be varied, most commonly described as a global subendocardial enhancement. However, it can involve both subendocardial and subepicardial regions, also with both patchy and diffuse distributions. 29 In a recent meta-analysis, LGE sequence showing hyper enhancement at the apex, suggestive of fibrosis in patient with hypertrophic cardiomyopathy. Ao = aorta; LA = left atrium; LGE = late gadolinium enhancement; LV = left ventricle; SSFP = steady-state free precision presence of diffuse gadolinium enhancement was associated with poor prognosis. 30 Hence, late gadolinium enhancement imaging in patients with AL cardiac amyloidosis provides prognostic information over biomarkers. Additionally, the prognosis of cardiac amyloidosis depends upon the type of amyloid protein deposition. [31] [32] [33] Query amyloid late enhancement (QALE) score has been recently developed to improve the LGE-CMR's diagnostic accuracy in differentiating transthyretin-related amyloidosis (ATTR) and AL types of cardiac amyloidosis. 34 By differentiating different types of cardiac amyloidosis, the QALE score has created a new avenue for LGE-CMR imaging as a possibility to avoid biopsy in patients with cardiac amyloidosis (Figures 4 and 5 ).
| Myocarditis
Myocarditis presents clinically as a flu-like illness with positive cardiac enzymes, along with wall-motion abnormalities without CAD.
An endomyocardial biopsy is currently gold standard for the diagnosis. Cardiac magnetic resonance's accuracy of diagnosis of myocarditis has been increased by Lake Louise criteria as suggested by a large consensus group. 5 Authors recommend the combined use of three tissue markers: (1) regional or global hyper signal intensity on T2-weighted images, (2) increased early gadolinium enhancement, and (3) at least one focal lesion on LGE with a nonischemic distribution. When two or more of these tissue-based criteria were positive, myocarditis could be predicted with a diagnostic accuracy of 78% as compared with EMB. 5 Studies have shown with the addition of CMR imaging to biopsy, the accuracy in diagnosis increases to 95%. 7 The pattern of LGE in patients with myocarditis is most frequently subepicardial extending toward mid-myocardium and sparing the subendocardium with a patchy distribution, frequently in inferior and lateral walls. 35 With the resolution of myocarditis, the enhancement regresses and there may be no LGE or mid-myocardial enhancement similar to DCM patients. In a recent study, LGE was found to be the best independent predictor of overall and cardiovascular mortality in a population with biopsy-proven myocarditis ( Figure 6 ). 
| Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Diagnoses of ARVC are based on a set of major and minor criteria which include comprehensive assessment of electrical, anatomical, and functional abnormalities. 37 Right ventricle is difficult to image by transthoracic echo, but CMR provides good visualization and is considered gold standard. In a study by Tandri 
| Pulmonary artery hypertension (PAH)
The role of LGE-CMR in patients with PAH has been extensively studied over a past decade. 39, 40 In general, majority of patients with PAH demonstrate LGE at RV insertion points. The presence of LGE at RV insertion point is a predictor of RV failure. 41, 42 A recent study by Freed et al has suggested that the presence of LGE at RV insertion points is an independent predictor of adverse outcomes in patients with PAH. 41 
| Pericardial disease
Constrictive pericarditis (CP) is characterized by thick pericardial fibrosis and frequent calcification that progressively leads to debilitating HF with constrictive physiology. Normal pericardium is thin (<2 mm) and a poorly vascularized structure which has no significant
LGE after contrast administration. Presence of pericardial LGE was more frequently associated with histological findings of pericardial inflammation, including increased neovascularization, fibroblast proliferation, and granulation tissue. 43 In a small study by Feng et al, a trial of anti-inflammatory therapy based on presence of LGE in pericardium was associated with resolution of constrictive physiology and clinical improvement (Figure 8 ). 
| Cardiac masses
Cardiac magnetic resonance plays an important role in the evaluation of cardiac masses of non-neoplastic and neoplastic origin, adding "precision" to diagnosis using a noninvasive imaging modality. Cardiac masses are usually evaluated in the context of adjacent structures, regional wall motion, vascularity, and surface demarcation. Early gadolinium enhancement with high signal intensity is seen in vascular tumors such as hemangioma or angiosarcoma, whereas a thrombus or pericardial cyst has no contrast uptake and therefore appears black. However, chronic and well-organized thrombus may contain peripheral fibrous tissue which shows Gd enhancement. 44 The presence of LGE on CMR is due to direct tumor invasion or necrosis which allows for intracellular expansion of Gd. Myxomas (most common primary cardiac tumor) are generally well defined, smooth, and pedunculated mass located in the atria. As myxomas are made up of a mixture of tissue, necrosis, fibrosis, and foci of hemorrhage, it typically shows patchy LGE. 45 On contrary to myxomas, 
| Electrophysiological procedures
Fluoroscopy plays a vital role during electrophysiological (EP)
procedures. 47, 48 The increased radiation exposure to physicians and patients is harmful, and hence, nonfluoroscopic techniques should be used when possible. Cardiac magnetic resonance offers less radiation exposure to both patients and providers during EP procedures. 49 Additionally, the excellent spatial and temporal resolution of CMR provide an enhanced visualization of cardiac structures as well as better segregation between damaged and normal tissue. A technique using 3D CMR angiography has been used to identify pulmonary vein anatomic variants (probable foci triggering atrial fibrillation [AF]) and assist in planning of AF ablation. 50 An identification of abnormal foci producing AF before the procedure allows the electrophysiologist in selection of catheter, type of procedure, and minimizes the procedure-related complications. Monomorphic ventricular tachycardia (MVT) (a life-threatening rhythm disorder) usually originates from scar.
As described, LGE-CMR is the most reliable method to characterize regions of the scar tissue in any type of cardiomyopathy.
The border-zone area of the scar tissue can give rise to MVT. 51, 52 The LGE-CMR helps to correlate the scar morphology to possible MVT ablation sites, allowing higher successful rates of MVT ablation procedure.
| Specific Population
Traditional evaluation of CAD with SPECT imaging has lower sensitivity in women compared with men. 6 The use of stress CMR allows us to get higher diagnostic accuracy in specific populations such as women. Women with signs and symptoms of ischemia and nonobstructive CAD are more likely to present with coronary microvascular dysfunction (CMD). The assessment of myocardial perfusion with CMR allows us to detect CMD in this specific population. 53 Cardiac magnetic resonance is considered to be a gold standard imaging technique in measurement of LV function and volumes. 54, 55 Reduced LV ejection fraction (LVEF) (ie, ≤35%) is considered as a marker for increased risk of SCD in patients with ischemic and nonischemic cardiomyopathies. Use of ICD is recommended for primary prevention in these patients who have a greater risk of SCD. 56 However, the absolute number of SCD is much higher in patients with preserved LVEF given that this is a much larger subgroup. 57 MUSTT study has highlighted that LVEF alone has lower sensitivity and specificity in predicting SCD. 58 Evidence suggests that the focal or diffuse myocardial fibrosis helps stratify the risk of SCD. 24 The extent and regions of myocardial fibrosis provide a substrate for ventricular arrhythmias leading to SCD. 59 The focal myocardial fibrosis can be readily detected by LGE-CMR. However, to identify the diffuse myocardial fibrosis T1 mapping techniques with quantification of extracellular volume can be used. 60 The presence of myocardial fibrosis can help clinicians to identify the possible candidates for ICD placement to prevent SCD. 55 
| CON CLUS ION
The LGE-CMR has distinct advantages over other imaging modali- LGE sequence shows enhancement of the apex, suggesting infarction and subsequent long serpiginous thrombus formation. LA = left atrium; LGE = late gadolinium enhancement; LV = left ventricle; SSFP = steady-state free precision of cardiovascular diseases is an area of special emphasis to move the field forward.
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